| Literature DB >> 28656377 |
Cesar E Escamilla-Ocañas1, Carlos R Cámara-Lemarroy1,2, Leonel Cantú-Martinez1, Héctor R Martínez3,4.
Abstract
Weight loss dietary supplements are used with some frequency by an increasingly overweight population. Some products are not adequately regulated and may pose potential health risks. We report two new cases of acute toxic leukoencephalopathy (ATL) due to the use of a supplement marketed as a thermogenic weight loss aid. ATL is a heterogeneous clinic-radiological entity that has been associated with various compounds, such as chemotherapeutic drugs and immunomodulators. It is characterized by an often reversible periventricular and infratentorial demyelination. The commercialization of non-regulated weight loss products continues to be a health risk in our population.Entities:
Keywords: Dietary supplements; Leukoencephalopathy; MRI; Toxic leukoencephalopathy; White matter
Mesh:
Substances:
Year: 2017 PMID: 28656377 DOI: 10.1007/s10072-017-3028-0
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307